# US 2013/0158430 A1 · Autonomous, ambulatory analyte monitor or drug delivery device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0158430 A1
- Document ID: US20130158430A1
- Status: Published application
- Kind: A1
- Application number: 13/669,366
- Filed: 2012-11-05
- Published: 2013-06-20
- Earliest claimed: 2002-02-08
- Assignees: Intuity Medical, Inc.
- Inventors: John Gregory ACETI; Sterling Eduard McBRIDE; Richard Morgan MORONEY; Christopher Carter GREGORY; Peter John ZANZUCCHI
- Web page: https://patentgrep.com/patent/US20130158430A1

## CPC

- A61B 5/150984: {Microneedles or microblades}
- A61B 5/1411: {by percutaneous method, e.g. by lancet}
- A61B 5/14514: {using means for aiding extraction of interstitial fluid, e.g. microneedles or suction}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- A61B 5/1455: using optical sensors, e.g. spectral photometrical oximeters
- A61B 5/150022: {for capillary blood or interstitial fluid}
- A61B 5/150076: {by heating}
- A61B 5/150213: {Venting means}
- A61B 5/150389: {Hollow piercing elements, e.g. canulas, needles, for piercing the skin}
- A61B 5/150503: {Single-ended needles (hollow piercing element tip design A61B5/150396)}
- A61B 5/150526: {Curved or bent needles}
- A61B 5/150755: {Blood sample preparation for further analysis, e.g. by separating blood components or by mixing}
- A61B 5/15087: {short range, e.g. between console and disposable (using implanted devices A61B5/150877)}
- A61B 5/150969: {Low-profile devices which resemble patches or plasters, e.g. also allowing collection of blood samples for testing}
- A61B 5/15109: {Fully automatically triggered, i.e. the triggering does not require a deliberate action by the user, e.g. by contact with the patient's skin}
- A61B 5/15119: {comprising shape memory alloys}
- A61B 5/15123: {comprising magnets or solenoids}
- A61B 5/15146: {Devices loaded with multiple lancets simultaneously, e.g. for serial firing without reloading, for example by use of stocking means. (multiple simultaneous cutting or piercing A61B5/150977)}
- A61B 5/15153: {Multiple piercing elements stocked in a single compartment}
- A61B 5/15163: {Characterized by propelling the piercing element in an axial direction relative to the disc}
- A61B 5/155: {Devices} specially adapted for continuous or multiple sampling, e.g. at predetermined intervals {(devices loaded with multiple lancets simultaneously A61B5/15146)}
- A61B 5/157: {Devices} characterised by integrated means for measuring characteristics of blood
- A61B 5/681: {Wristwatch-type devices}
- A61B 5/6833: {Adhesive patches}
- A61M 37/0015: {by using microneedles}
- G01N 33/491: {by separating the blood components (G01N15/05 takes precedence)}
- A61B 2560/0412: Low-profile patch shaped housings
- A61B 2560/0443: Modular apparatus
- A61M 2037/0023: {Drug applicators using microneedles}
- A61M 2037/0038: {having a channel at the side surface}
- A61M 2209/088: on the body
- A61M 2230/201: Glucose concentration
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention relates to analyte monitoring/drug delivery device. The invention is suited for monitoring various blood constituents such as glucose. The device has a housing that at least partially encloses a plurality of microneedles disposed on a carrier and an electronics portion. Each microneedle is in fluid communication with a corresponding microchannel. Each microneedle is individually addressable. That is, each microneedle can be extended and retracted individually via an actuator. The invention can optionally provide for calibration without intervention of the user and can also provide for semi-continuous monitoring for day and night time. The invention can provide up to four, or more, weeks of operation. The invention can provide for a device that is relatively small in size, and therefore unobtrusive. The invention can also provide for device with remote control and interactive electronics. The invention may be also used for the delivery of various pharmaceutical agents.

## Claims

### Claim at position 1

1-59. (canceled)

### Claim 60

An analyte monitoring device operable to draw a fluid sample from a subject, the device comprising:
a plurality of microneedles disposed on a carrier,
a plurality of microchannels, wherein each of the plurality of microneedles is at least intermittently in fluid communication with a corresponding microchannel, wherein each of the plurality of microneedles is connected to and moveable with a corresponding fluidic capture site and is constructed and arranged to collect the fluid sample from the subject, wherein the corresponding fluidic capture site is configured to fluidly couple to and deliver the fluid sample to at least one of the plurality of microchannels, and wherein each microchannel is associated with a reagent,
at least one actuator operable to extend each microneedle and corresponding fluidic capture site to collect the fluid sample from the subject and to deliver the fluid sample to the at least one of the plurality of microchannels, and
a controller operable to initiate analyte testing of the fluid sample.

### Claim 61 (depends on 60)

The device of claim 60 wherein each of the first plurality of microneedles has an internal diameter in the range of about 25 to 200 micrometers.

### Claim 62 (depends on 60)

The device of claim 60 wherein each of the first plurality of microneedles is fabricated from at least one of metal, plastic, glass and crystal.

### Claim 63 (depends on 60)

The device of claim 60 wherein each of the first plurality of microneedles has a distal end that is operable to penetrate into a skin surface to a maximum of about 2.5 mm.

### Claim 64 (depends on 60)

The device of claim 60 wherein the fluid sample is substantially blood.

### Claim 65 (depends on 60)

The device of claim 60 wherein each of the first plurality of microneedles is at least intermittently in fluid communication with a microchannel via a conduit.

### Claim 66 (depends on 60)

The device of claim 60 wherein each microchannel is operable to store the fluid sample and accumulation of the fluid sample in the microchannel is entirely dependent on capillary forces.

### Claim 67 (depends on 60)

The device of claim 60 wherein each of the microchannels has at least one internal surface that is at least partially coated with at least one insoluble material to enhance the capillary forces and minimize coagulation.

### Claim 68 (depends on 60)

The device of claim 60 wherein each of the first plurality of microneedles is dimensioned for volumes of fluid in the range of about 50-500 nanoliters.

### Claim 69 (depends on 60)

The device of claim 60 comprising a detector operable to determine when the fluid sample completely fills at least one microchannel such that the accumulation of the fluid sample with the associated microneedle may be terminated.

### Claim 70 (depends on 60)

The device of claim 60 wherein at least one microchannel is in fluid communication with at least one reagent operable to assay for analytes selected from the group of (a) glucose, (b) cholesterol, (c) ethanol, (d) digoxin, (e) HDL cholesterol, (f) lithium, (g) sodium, (h) phenytoin, (i) therophylline, (j) cyclosporine, (k) cancer chemotheraphy drugs, (l) DNA, (m) RNA, (n) extended phenytonin sodium, (o) warfarin sodium, and (p) proteins derived from blood.

### Claim 71 (depends on 60)

The device of claim 60 wherein at least two microchannels are associated with a single microneedle so that multiple assays can be performed using a single microneedle.

### Claim 72 (depends on 60)

The device of claim 60 wherein at least one monitoring microchannel is sealed with a polymer.

### Claim 73 (depends on 60)

The device of claim 60 wherein the plurality of microneedles, plurality of microchannels and the reagent are contained in a disposable cartridge.

### Claim 74 (depends on 73)

The device of claim 73, further comprising a reusable module receiving the disposable cartridge therein.

### Claim 75 (depends on 74)

The device of claim 74, wherein the disposable cartridge further comprises an electromechanical interface for the reusable module.

### Claim 76 (depends on 60)

The device of claim 60, wherein each of the plurality of microneedles comprises an internal bore in direct fluid communication with a respective microchannel.

### Claim 77 (depends on 76)

The device of claim 76, wherein each of the plurality of microchannels is disposed directly above a respective microneedle.

### Claim 78 (depends on 77)

The device of claim 77, further comprising a cover at least partially enclosing at least one of the plurality of microchannels.

### Claim 79 (depends on 60)

The device of claim 60, further comprising an optical sensor constructed and arranged to make colorimetric measurements for determining a concentration of the analyte contained in the fluid sample.

### Claim 80 (depends on 79)

The device of claim 79, wherein each microchannel and the associated reagent define a reaction site, and the device further comprising a blood detection sensor constructed and arranged to detect the presence of blood at the reaction site.

### Claim 81 (depends on 80)

The device of claim 80, wherein the blood detection sensor comprises the optical sensor, and the optical sensor is constructed and arranged to detect the presence of blood at the reaction site prior to the determination of the concentration of the analyte contained in the fluid sample.
